Symbols / AMWL Stock $7.89 -3.25% American Well Corporation

Healthcare • Health Information Services • United States • NYQ
AMWL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Dr. Ido Schoenberg M.D.
Exch · Country NYQ · United States
Market Cap 131.75M
Enterprise Value -27.08M
Income -87.88M
Sales 237.38M
FCF (ttm) -7.37M
Book/sh 13.65
Cash/sh 10.77
Employees 562
Insider 10d —
IPO Sep 17, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -4.69
PEG —
P/S 0.56
P/B 0.58
P/C —
EV/EBITDA 0.57
EV/Sales -0.11
Quick Ratio 2.83
Current Ratio 3.09
Debt/Eq 1.65
LT Debt/Eq —
EPS (ttm) -5.43
EPS next Y -1.68
EPS Growth —
Revenue Growth -17.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-04
Earnings (prior) 2026-05-05
ROA -13.60%
ROE -31.84%
ROIC —
Gross Margin 53.42%
Oper. Margin -31.75%
Profit Margin -37.02%
Shs Outstand 15.06M
Shs Float 14.15M
Insider Own 5.51%
Instit Own 42.36%
Short Float 2.12%
Short Ratio 6.00
Short Interest 305.53K
52W High 9.15
vs 52W High -13.83%
52W Low 3.71
vs 52W Low 112.53%
Beta —
Impl. Vol. 88.67%
Rel Volume 0.94
Avg Volume 77.57K
Volume 72.59K
Target (mean) $7.50
Tgt Median $7.25
Tgt Low $6.50
Tgt High $9.00
# Analysts 4
Recom Hold
Prev Close $8.15
Price $7.88
Change -3.25%
About

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$7.50
Mean price target
2. Current target
$7.89
Latest analyst target
3. DCF / Fair value
$-8.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.89
Low
$6.50
High
$9.00
Mean
$7.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-06 main TD Cowen Hold → Hold $8
2026-05-06 main Morgan Stanley Equal-Weight → Equal-Weight $7
2026-02-13 main Stifel Hold → Hold $5
2025-12-18 main Morgan Stanley Equal-Weight → Equal-Weight $6
2025-11-05 main Wells Fargo Overweight → Overweight $9
2025-11-05 main Stifel Hold → Hold $6
2025-08-07 main Wells Fargo Overweight → Overweight $12
2025-05-23 reit Piper Sandler Neutral → Neutral $8
2025-05-08 main UBS Neutral → Neutral $9
2025-05-02 main Stifel Hold → Hold $8
2025-05-02 reit Needham Hold → Hold —
2025-04-10 main Truist Securities Hold → Hold $8
2025-02-14 main Truist Securities Hold → Hold $12
2025-02-13 main Stifel Hold → Hold $10
2025-02-13 reit Needham Hold → Hold —
2025-01-13 up Wells Fargo Equal-Weight → Overweight $15
2024-12-17 main Morgan Stanley Equal-Weight → Equal-Weight $11
2024-10-31 reit Needham — → Hold —
2024-09-24 reit Needham — → Hold —
2024-08-06 main Wells Fargo Equal-Weight → Equal-Weight $15
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 MCNEICE PAUL FRANCIS Officer — 383 $5.30 $2,030
2026-04-01 GOTLIB PHYLLIS Officer — 3,706 $5.30 $19,642
2026-04-01 ZAMANSKY DMITRY Chief Technology Officer — 5,575 $5.30 $29,548
2026-03-04 HIRSCHHORN MARK J Chief Financial Officer — 50,413 $0.00 $0
2026-03-04 MCNEICE PAUL FRANCIS Officer — 8,066 $0.00 $0
2026-03-04 GOTLIB PHYLLIS Officer — 50,413 $0.00 $0
2026-03-04 ZAMANSKY DMITRY Chief Technology Officer — 50,413 $0.00 $0
2026-03-02 HIRSCHHORN MARK J Chief Financial Officer — 10,796 $5.24 $56,571
2026-03-02 MCNEICE PAUL FRANCIS Officer — 130 $5.24 $681
2026-03-02 GOTLIB PHYLLIS Officer — 3,573 $5.24 $18,723
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
249.32
-1.98%
254.36
-1.81%
259.05
-6.55%
277.19
Operating Revenue
226.69
-2.29%
232.00
+0.07%
231.85
-5.47%
245.27
Cost Of Revenue
116.47
-25.06%
155.41
-5.40%
164.29
+2.41%
160.42
Reconciled Cost Of Revenue
116.47
-25.06%
155.41
-5.39%
164.27
+2.41%
160.41
Gross Profit
132.86
+34.27%
98.95
+4.42%
94.76
-18.85%
116.77
Operating Expense
238.13
-24.76%
316.49
-9.68%
350.42
-10.75%
392.62
Research And Development
72.86
-15.34%
86.06
-18.67%
105.83
-23.58%
138.49
Selling General And Administration
131.31
-33.50%
197.45
-7.35%
213.10
-6.53%
227.98
Selling And Marketing Expense
43.27
-43.28%
76.27
-11.78%
86.46
+5.92%
81.63
General And Administrative Expense
88.05
-27.34%
121.17
-4.32%
126.64
-13.47%
146.35
Other Gand A
88.05
-27.34%
121.17
-4.32%
126.64
-13.47%
146.35
Total Expenses
354.60
-24.86%
471.90
-8.32%
514.71
-6.93%
553.04
Operating Income
-105.27
+51.61%
-217.53
+14.91%
-255.66
+7.32%
-275.85
Total Operating Income As Reported
-105.27
+51.61%
-217.53
+68.57%
-692.14
-150.91%
-275.85
EBITDA
-71.31
+61.36%
-184.56
+17.66%
-224.15
+10.23%
-249.69
Normalized EBITDA
-79.95
+56.68%
-184.56
-186.92%
212.33
+185.04%
-249.69
Reconciled Depreciation
33.96
+2.99%
32.97
+4.64%
31.51
+20.43%
26.17
EBIT
-105.27
+51.61%
-217.53
+14.91%
-255.66
+7.32%
-275.85
Total Unusual Items
8.63
0.00
+100.00%
-436.48
0.00
Total Unusual Items Excluding Goodwill
8.63
0.00
+100.00%
-436.48
0.00
Special Income Charges
8.63
0.00
+100.00%
-436.48
0.00
Impairment Of Capital Assets
0.00
0.00
-100.00%
436.48
0.00
Net Income
-95.70
+54.02%
-208.14
+69.17%
-675.16
-149.66%
-270.43
Pretax Income
-92.84
+55.10%
-206.78
+69.26%
-672.72
-149.41%
-269.73
Net Non Operating Interest Income Expense
3.80
-64.65%
10.76
-44.61%
19.42
+217.20%
6.12
Net Interest Income
3.80
-64.65%
10.76
-44.61%
19.42
+217.20%
6.12
Interest Income Non Operating
3.80
-64.65%
10.76
-44.61%
19.42
+217.20%
6.12
Interest Income
3.80
-64.65%
10.76
-44.61%
19.42
+217.20%
6.12
Other Income Expense
8.63
—
-436.48
—
Gain On Sale Of Business
8.63
0.00
0.00
—
Tax Provision
0.43
-84.22%
2.75
-28.73%
3.86
+5931.25%
0.06
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
1.81
0.00
+100.00%
-91.66
0.00
Net Income Including Noncontrolling Interests
-94.97
+55.34%
-212.64
+68.69%
-679.17
-149.63%
-272.07
Net Income From Continuing Operation Net Minority Interest
-95.70
+54.02%
-208.14
+69.17%
-675.16
-149.66%
-270.43
Net Income From Continuing And Discontinued Operation
-95.70
+54.02%
-208.14
+69.17%
-675.16
-149.66%
-270.43
Net Income Continuous Operations
-94.97
+55.34%
-212.64
+68.69%
-679.17
-149.63%
-272.07
Minority Interests
-0.73
-116.31%
4.50
+12.18%
4.01
+143.88%
1.64
Normalized Income
-102.52
+50.74%
-208.14
+36.99%
-330.35
-22.16%
-270.43
Net Income Common Stockholders
-95.70
+54.02%
-208.14
+69.17%
-675.16
-149.66%
-270.43
Diluted EPS
-5.96
+57.06%
-13.88
+70.84%
-47.60
-140.40%
-19.80
Basic EPS
-5.96
+57.06%
-13.88
+70.84%
-47.60
-140.40%
-19.80
Basic Average Shares
16.05
+6.99%
15.00
+5.54%
14.21
+3.65%
13.71
Diluted Average Shares
16.05
+6.99%
15.00
+5.54%
14.21
+3.65%
13.71
Diluted NI Availto Com Stockholders
-95.70
+54.02%
-208.14
+69.17%
-675.16
-149.66%
-270.43
Depreciation Amortization Depletion Income Statement
33.96
+2.99%
32.98
+4.71%
31.49
+20.41%
26.15
Depreciation And Amortization In Income Statement
33.96
+2.99%
32.98
+4.71%
31.49
+20.41%
26.15
Earnings From Equity Interest Net Of Tax
-1.70
+45.47%
-3.11
-20.08%
-2.59
-13.70%
-2.28
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
323.79
-25.73%
435.97
-26.07%
589.71
-51.57%
1,217.56
Current Assets
246.68
-22.18%
316.99
-29.49%
449.58
-28.25%
626.62
Cash Cash Equivalents And Short Term Investments
182.33
-20.14%
228.32
-38.63%
372.04
-30.92%
538.55
Cash And Cash Equivalents
182.33
-20.14%
228.32
-38.63%
372.04
-30.92%
538.55
Other Short Term Investments
—
—
—
—
Receivables
49.69
-30.87%
71.89
+32.76%
54.15
-7.24%
58.37
Accounts Receivable
49.69
-30.87%
71.89
+32.76%
54.15
-7.24%
58.37
Gross Accounts Receivable
59.16
-25.23%
79.12
+40.19%
56.44
-6.34%
60.26
Allowance For Doubtful Accounts Receivable
-9.46
-30.78%
-7.24
-215.84%
-2.29
-21.60%
-1.88
Inventory
1.19
-58.47%
2.86
-57.04%
6.65
-23.86%
8.74
Prepaid Assets
—
—
—
—
Current Deferred Assets
2.66
+5.85%
2.51
+11.10%
2.26
+62.27%
1.39
Restricted Cash
—
—
—
—
Other Current Assets
10.81
-5.32%
11.42
-21.15%
14.48
-25.98%
19.57
Total Non Current Assets
77.11
-35.19%
118.97
-15.09%
140.12
-76.29%
590.94
Net PPE
4.16
-45.18%
7.58
-31.26%
11.03
-24.08%
14.52
Gross PPE
15.49
-25.06%
20.67
-13.25%
23.82
-10.73%
26.69
Accumulated Depreciation
-11.33
+13.41%
-13.09
-2.26%
-12.80
-5.19%
-12.17
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
11.38
-10.94%
12.78
+0.79%
12.68
+1.53%
12.49
Other Properties
3.93
-45.44%
7.20
-31.09%
10.45
-22.62%
13.51
Leases
0.18
-74.16%
0.69
-1.01%
0.69
+0.00%
0.69
Goodwill And Other Intangible Assets
66.07
-34.93%
101.54
-15.56%
120.25
-78.91%
570.26
Goodwill
—
—
0.00
-100.00%
435.28
Other Intangible Assets
66.07
-34.93%
101.54
-15.56%
120.25
-10.91%
134.98
Investments And Advances
0.00
-100.00%
1.50
+27.12%
1.18
0.00
Long Term Equity Investment
0.00
-100.00%
1.50
+27.12%
1.18
0.00
Non Current Deferred Assets
4.46
-16.65%
5.35
+11.64%
4.79
+41.19%
3.39
Other Non Current Assets
2.42
-19.58%
3.01
+4.52%
2.88
+4.01%
2.77
Total Liabilities Net Minority Interest
76.00
-36.52%
119.72
+9.32%
109.52
-18.09%
133.71
Current Liabilities
73.21
-34.20%
111.26
+18.62%
93.80
-17.76%
114.06
Payables And Accrued Expenses
12.23
-33.04%
18.27
+13.19%
16.14
-36.76%
25.52
Payables
1.65
-67.12%
5.01
+3.10%
4.86
-32.78%
7.24
Accounts Payable
1.65
-67.12%
5.01
+3.10%
4.86
-32.78%
7.24
Current Accrued Expenses
10.58
-20.15%
13.25
+17.53%
11.28
-38.34%
18.29
Pensionand Other Post Retirement Benefit Plans Current
22.56
-13.21%
25.99
+66.88%
15.57
-40.54%
26.19
Current Debt And Capital Lease Obligation
3.63
-1.57%
3.69
+3.07%
3.58
+17.11%
3.06
Current Capital Lease Obligation
3.63
-1.57%
3.69
+3.07%
3.58
+17.11%
3.06
Current Deferred Liabilities
22.62
-57.50%
53.23
+14.81%
46.37
-6.34%
49.51
Current Deferred Revenue
22.62
-57.50%
53.23
+14.81%
46.37
-6.34%
49.51
Other Current Liabilities
12.17
+20.66%
10.09
-16.92%
12.14
+24.13%
9.78
Total Non Current Liabilities Net Minority Interest
2.79
-67.08%
8.46
-46.18%
15.72
-19.99%
19.65
Long Term Debt And Capital Lease Obligation
0.89
-80.23%
4.51
-45.03%
8.21
-30.38%
11.79
Long Term Capital Lease Obligation
0.89
-80.23%
4.51
-45.03%
8.21
-30.38%
11.79
Non Current Deferred Liabilities
0.82
-70.58%
2.78
-54.36%
6.09
-3.15%
6.29
Non Current Deferred Revenue
0.82
-70.58%
2.78
-54.36%
6.09
-3.15%
6.29
Other Non Current Liabilities
1.07
-8.12%
1.17
-17.89%
1.43
-9.47%
1.57
Stockholders Equity
235.58
-22.70%
304.77
-34.35%
464.22
-56.37%
1,063.88
Common Stock Equity
235.58
-22.70%
304.77
-34.35%
464.22
-56.37%
1,063.88
Capital Stock
0.17
+5.77%
0.16
+7.59%
0.14
-94.76%
2.77
Common Stock
0.17
+5.77%
0.16
+7.59%
0.14
-94.76%
2.77
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
16.43
+5.52%
15.57
+7.94%
14.42
+4.09%
13.86
Ordinary Shares Number
16.43
+5.52%
15.57
+7.94%
14.42
+4.09%
13.86
Additional Paid In Capital
2,309.14
+1.00%
2,286.38
+2.18%
2,237.50
+3.58%
2,160.11
Retained Earnings
-2,061.63
-4.87%
-1,965.92
-11.84%
-1,757.78
-62.45%
-1,082.03
Gains Losses Not Affecting Retained Earnings
-12.10
+23.62%
-15.84
-1.21%
-15.65
+7.77%
-16.97
Treasury Stock
—
—
—
—
Minority Interest
12.21
+6.39%
11.47
-28.15%
15.97
-20.06%
19.97
Other Equity Adjustments
-12.10
+23.62%
-15.84
-1.21%
-15.65
+7.77%
-16.97
Total Equity Gross Minority Interest
247.79
-21.65%
316.24
-34.14%
480.19
-55.70%
1,083.85
Total Capitalization
235.58
-22.70%
304.77
-34.35%
464.22
-56.37%
1,063.88
Working Capital
173.47
-15.68%
205.73
-42.18%
355.79
-30.59%
512.56
Invested Capital
235.58
-22.70%
304.77
-34.35%
464.22
-56.37%
1,063.88
Total Debt
4.52
-44.84%
8.20
-30.42%
11.79
-20.60%
14.84
Capital Lease Obligations
4.52
-44.84%
8.20
-30.42%
11.79
-20.60%
14.84
Net Tangible Assets
169.51
-16.59%
203.23
-40.92%
343.97
-30.32%
493.62
Tangible Book Value
169.51
-16.59%
203.23
-40.92%
343.97
-30.32%
493.62
Investmentsin Joint Venturesat Cost
0.00
-100.00%
1.50
+27.12%
1.18
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-65.95
+48.21%
-127.34
+14.16%
-148.34
+22.87%
-192.32
Cash Flow From Continuing Operating Activities
-65.95
+48.21%
-127.34
+14.16%
-148.34
+22.87%
-192.32
Net Income From Continuing Operations
-94.97
+55.34%
-212.64
+68.69%
-679.17
-149.63%
-272.07
Depreciation Amortization Depletion
33.96
+2.99%
32.97
+4.64%
31.51
+20.43%
26.17
Depreciation And Amortization
33.96
+2.99%
32.97
+4.64%
31.51
+20.43%
26.17
Other Non Cash Items
4.64
+59.22%
2.92
+8.28%
2.69
-79.97%
13.44
Stock Based Compensation
22.01
-53.70%
47.54
-34.19%
72.25
+6.75%
67.67
Provisionand Write Offof Assets
2.74
-61.30%
7.09
+570.77%
1.06
+31.14%
0.81
Asset Impairment Charge
0.50
-73.59%
1.89
-99.57%
436.48
0.00
Deferred Tax
-1.11
-356.79%
-0.24
-0.41%
-0.24
+90.41%
-2.52
Deferred Income Tax
-1.11
-356.79%
-0.24
-0.41%
-0.24
+90.41%
-2.52
Operating Gains Losses
-6.94
-323.09%
3.11
+20.08%
2.59
+13.70%
2.28
Change In Working Capital
-26.80
-168.46%
-9.98
+35.64%
-15.51
+44.81%
-28.10
Change In Receivables
12.22
+148.86%
-25.01
-870.07%
3.25
+139.90%
-8.14
Changes In Account Receivables
12.22
+148.86%
-25.01
-870.07%
3.25
+139.90%
-8.14
Change In Inventory
1.17
-38.40%
1.90
-8.82%
2.08
+272.74%
-1.21
Change In Prepaid Assets
0.87
-66.51%
2.60
-44.59%
4.69
+3015.53%
-0.16
Change In Payables And Accrued Expense
-7.06
-168.70%
10.28
+158.73%
-17.50
-518.46%
4.18
Change In Accrued Expense
-3.64
-136.00%
10.12
+166.83%
-15.14
-268.92%
8.96
Change In Payable
-3.42
-2249.69%
0.16
+106.73%
-2.36
+50.61%
-4.78
Change In Account Payable
-3.42
-2249.69%
0.16
+106.73%
-2.36
+50.61%
-4.78
Change In Other Working Capital
-34.78
-7514.93%
0.47
+105.89%
-7.96
+64.65%
-22.51
Change In Other Current Assets
0.78
+458.99%
-0.22
-185.53%
-0.08
+67.66%
-0.23
Change In Other Current Liabilities
—
0.00
0.00
+100.00%
-0.03
Investing Cash Flow
17.10
+191.70%
-18.65
+2.69%
-19.17
-64.82%
-11.63
Cash Flow From Continuing Investing Activities
17.10
+191.70%
-18.65
+2.69%
-19.17
-64.82%
-11.63
Net PPE Purchase And Sale
-0.02
+82.35%
-0.12
+38.02%
-0.19
+34.25%
-0.29
Purchase Of PPE
-0.02
+82.35%
-0.12
+38.02%
-0.19
+34.25%
-0.29
Capital Expenditure
-0.02
+99.86%
-15.22
+0.17%
-15.25
-45.96%
-10.45
Capital Expenditure Reported
0.00
+100.00%
-15.10
-0.31%
-15.06
-48.26%
-10.15
Net Investment Purchase And Sale
-1.00
0.00
0.00
-100.00%
0.78
Purchase Of Investment
-1.00
0.00
+100.00%
-389.99
+21.88%
-499.22
Sale Of Investment
0.00
0.00
-100.00%
389.99
-22.00%
500.00
Net Business Purchase And Sale
18.12
+628.43%
-3.43
+12.50%
-3.92
-100.00%
-1.96
Purchase Of Business
-0.20
+94.29%
-3.43
+12.50%
-3.92
-100.00%
-1.96
Gain Loss On Sale Of Business
-8.63
0.00
0.00
—
Financing Cash Flow
0.84
-39.17%
1.38
-35.68%
2.15
+159.44%
-3.61
Cash Flow From Continuing Financing Activities
0.84
-39.17%
1.38
-35.68%
2.15
+159.44%
-3.61
Net Common Stock Issuance
-0.00
-33.33%
-0.00
+99.49%
-0.59
-62.78%
-0.36
Common Stock Payments
-0.00
-33.33%
-0.00
+99.49%
-0.59
-62.78%
-0.36
Repurchase Of Capital Stock
-0.00
-33.33%
-0.00
+99.49%
-0.59
-62.78%
-0.36
Proceeds From Stock Option Exercised
0.84
-39.02%
1.38
-49.36%
2.73
-66.84%
8.24
Net Other Financing Charges
—
—
—
-11.49
Changes In Cash
-48.01
+66.80%
-144.61
+12.55%
-165.36
+20.33%
-207.56
Effect Of Exchange Rate Changes
2.02
+127.85%
0.89
+177.53%
-1.14
-275.08%
-0.30
Beginning Cash Position
229.11
-38.55%
372.83
-30.87%
539.34
-27.82%
747.21
End Cash Position
183.12
-20.07%
229.11
-38.55%
372.83
-30.87%
539.34
Free Cash Flow
-65.97
+53.72%
-142.56
+12.86%
-163.59
+19.32%
-202.77
Income Tax Paid Supplemental Data
1.97
-52.03%
4.11
-17.95%
5.00
+190.37%
1.72
Common Stock Issuance
—
—
—
0.00
Earnings Losses From Equity Investments
1.70
-45.47%
3.11
+20.08%
2.59
+13.70%
2.28
Issuance Of Capital Stock
—
—
—
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
Sale Of Business
18.32
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category